Substituted benzylidene hydrazines for treating hyperglycemia, o

Details Substituted benzylidene hydrazines for treating hyperglycemia, o Substituted benzylidene hydrazines for treating hyperglycemia, o

1972-09-05

1976-09-21

Turner, V. D.

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Recombinant or stably-transformed bacterium encoding one or...

424327, A61K 31155

Patent

active

039820203

ABSTRACT:
Substituted benzylidene hydrazines e.g. N-(4-phenylbenzylidene)-N'-amidino hydrazine and their use as hypoglycemic-antihyperglycemic agents, anti-obesity agents and anti-inflammatory agents.

REFERENCES:
patent: 3658993 (1972-04-01), Kodama et al.
Derwent Abstract of Belgian Pat. No. 722136(1968).

Affiliated with

Also associated with

Rating

Substituted benzylidene hydrazines for treating hyperglycemia, o does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted benzylidene hydrazines for treating hyperglycemia, o, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted benzylidene hydrazines for treating hyperglycemia, o will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1414132